Annual Operating Expenses
$81.06 M
+$5.36 M+7.08%
December 31, 2023
Summary
- As of February 25, 2025, JANX annual total operating expenses is $81.06 million, with the most recent change of +$5.36 million (+7.08%) on December 31, 2023.
- During the last 3 years, JANX annual operating expenses has risen by +$76.22 million (+1573.80%).
- JANX annual operating expenses is now at all-time high.
Performance
JANX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$36.28 M
+$13.56 M+59.69%
September 30, 2024
Summary
- As of February 25, 2025, JANX quarterly total operating expenses is $36.28 million, with the most recent change of +$13.56 million (+59.69%) on September 30, 2024.
- Over the past year, JANX quarterly operating expenses has stayed the same.
- JANX quarterly operating expenses is now at all-time high.
Performance
JANX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
JANX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.1% | 0.0% |
| 3 y3 years | +1573.8% | 0.0% |
| 5 y5 years | +2049.6% | 0.0% |
JANX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +121.7% | at high | +140.2% |
| 5 y | 5-year | at high | +2049.6% | at high | +4292.4% |
| alltime | all time | at high | +2049.6% | at high | +4292.4% |
Janux Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $36.28 M(+59.7%) |
| Jun 2024 | - | $22.72 M(+6.1%) |
| Mar 2024 | - | $21.41 M(+15.1%) |
| Dec 2023 | $81.06 M(+7.1%) | $18.60 M(+1.5%) |
| Sep 2023 | - | $18.33 M(-15.9%) |
| Jun 2023 | - | $21.80 M(-2.3%) |
| Mar 2023 | - | $22.33 M(+5.8%) |
| Dec 2022 | $75.70 M | $21.11 M(+6.4%) |
| Sep 2022 | - | $19.84 M(+1.1%) |
| Jun 2022 | - | $19.63 M(+29.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $15.13 M(+0.2%) |
| Dec 2021 | $36.57 M(+655.0%) | $15.11 M(+25.2%) |
| Sep 2021 | - | $12.06 M(+79.1%) |
| Jun 2021 | - | $6.73 M(+152.8%) |
| Mar 2021 | - | $2.66 M(+61.0%) |
| Dec 2020 | $4.84 M(+28.4%) | $1.66 M(+31.8%) |
| Sep 2020 | - | $1.26 M(+13.6%) |
| Jun 2020 | - | $1.11 M(+33.9%) |
| Mar 2020 | - | $826.00 K |
| Dec 2019 | $3.77 M | - |
FAQ
- What is Janux Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Janux Therapeutics?
- What is Janux Therapeutics annual operating expenses year-on-year change?
- What is Janux Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Janux Therapeutics?
- What is Janux Therapeutics quarterly operating expenses year-on-year change?
What is Janux Therapeutics annual total operating expenses?
The current annual operating expenses of JANX is $81.06 M
What is the all time high annual operating expenses for Janux Therapeutics?
Janux Therapeutics all-time high annual total operating expenses is $81.06 M
What is Janux Therapeutics annual operating expenses year-on-year change?
Over the past year, JANX annual total operating expenses has changed by +$5.36 M (+7.08%)
What is Janux Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of JANX is $36.28 M
What is the all time high quarterly operating expenses for Janux Therapeutics?
Janux Therapeutics all-time high quarterly total operating expenses is $36.28 M
What is Janux Therapeutics quarterly operating expenses year-on-year change?
Over the past year, JANX quarterly total operating expenses has changed by $0.00 (0.00%)